Bayesian Capital Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $221K | Buy |
+23,600
| New | +$221K | 0.04% | 442 |
|
|
2024
Q3 | – | Sell |
-30,401
| Closed | -$680K | – | 937 |
|
|
2024
Q2 | $680K | Buy |
30,401
+19,400
| +176% | +$434K | 0.08% | 302 |
|
|
2024
Q1 | $303K | Buy |
+11,001
| New | +$303K | 0.03% | 551 |
|
|
2023
Q2 | – | Sell |
-8,200
| Closed | -$306K | – | 981 |
|
|
2023
Q1 | $306K | Buy |
+8,200
| New | +$306K | 0.04% | 502 |
|
|
2022
Q2 | – | Sell |
-4,146
| Closed | -$301K | – | 985 |
|
|
2022
Q1 | $301K | Buy |
+4,146
| New | +$301K | 0.04% | 520 |
|
|
2020
Q2 | – | Sell |
-10,800
| Closed | -$132K | – | 693 |
|
|
2020
Q1 | $132K | Buy |
+10,800
| New | +$132K | 0.03% | 645 |
|